|Event Name||OMICS International Generic Pharma 2016
Monday, October 31, 2016
Wednesday, November 02, 2016
TRYP Barcelona Apolo Hotel
|Cost||$99 - $1619
|Description||Generic Pharma 2016 conveys recent developments in Generic drug marketing and production of generic drugs and contract manufacturing. A complete knowledge of a scientific discipline that described the effects of generic drug marketing and generic Pharma now explores the Scope of generic drug marketing in industry. Generic Pharma 2016 provides detailed market, technology, and industry analyses to help readers quantify and qualify the market for prescription generic drugs. Important trends are identified and sales forecasts by product categories and major country markets these are based on industry sources and considered assessment of the regulatory environment, healthcare policies, demographics, and other factors that directly affect the generic drug market. The wider economic environment is also taken into account.
The scope of Generic Pharma discusses the implications of all the above-mentioned trends, in the context of the current size and growth of the generics market, both in global terms and analysed by the most important national markets. The nature and structure of the generics industry is discussed, and an update on M&A activity. With first-generation biopharmaceutical products reaching the end of their patent lives, a whole new market field—bio generics or bio similar is opening up, for those generics companies capable of (or prepared to buy-in) the technological expertise required. The international landscape is changing for generics as for all pharmaceuticals. China, India, Eastern European countries and Brazil are among rising centres of generic activity.